Therapy Areas: Hereditary Disorders
16 March 2023 - - The US Food and Drug Administration has cleared the Investigational New Drug Application for VX-264, a stem cell-derived, fully differentiated pancreatic islet cell therapy encapsula...
6 February 2023 - - US-based lung health management platform Aluna has completed a USD 15.3m series B round of financing to continue growing its solution among doctors and patients managing asthma, cy...
13 January 2023 - - The first patient has been dosed in the PHAGE clinical trial, evaluating bacteriophage therapy in adults with cystic fibrosis who carry Pseudomonas aeruginosa (...
11 January 2023 - - The Cystic Fibrosis Foundation will invest up to USD 15m in ReCode Therapeutics for the development of its messenger RNA therapy that could eventually provide a treatment option fo...
19 December 2022 - - US-based clinical messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has appointed John Markels, Ph.D., a pharmaceutical executive with over 35 yea...
15 December 2022 - SpliSense, an Israel-based biopharmaceutical company, announced on Wednesday that it has started a first-in-human, Phase 1/2 clinical trial of SPL84, the company's lead anti se...
Related Headlines